In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

European Heart Journal - Cardiovascular Pharmacotherapy

Cardiovascular Pharmacology and Pharmacotherapy

Specific focus on clinical cardiovascular pharmacology

Why a new journal?

The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area.

It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.

Editor-in-Chief:  Stefan Agewall FESC, NO 

Current volume: 3 (year 2017)

Issues per subscription: 4

Access your online Journal

Connect with us on Twitter using @ESC_Journals



Non ESC Members

ESC Members

Members of Working Group on Cardiovascular Pharmacotherapy

Print + Online


40 €

30 €


Not an ESC member yet? Join now

Already an ESC member? Order now

Updates on latest articles

New issue alert – Table of content

New advance articles alert

For authors

Before being published, all manuscripts go through double-blinded peer review by experienced international experts.

Submit your manuscript

If you would like more information, read the authors instructions

Publisher information

If you would like more information on reprints, rights/permissions and advertising, visit Publisher website.

Frequently asked questions

Looking for answers? Check here